Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis Clin Transl Sci. 2024; 17:e13908 Eriksson J, Chenel M, Sjögren E. Infectious diseasesJournalPBPK/PBBM Pharmetheus Affiliates Consultant Johanna Eriksson See bio Chief Research Officer Marylore Chenel See bio Principal Consultant, PBPK & PBBM Platform Scientific Lead Erik Sjögren See bio